Eris Lifesciences Ltd

NSE: ERIS · BSE: 540596 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹1,258.90
Market cap: ₹17,466 Cr
Revenue (annual): ₹3,129 Cr
Net profit (annual): ₹619.5 Cr
P/E (TTM): 27.1×Sector 50.4×
Promoter holding: 54.14%+0.22% QoQ
FII holding: 5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Management Change 2 Annual General Meeting 2 Price Movement Clarification 1 Financial Results 1 Employee Stock Options 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 Sep 2026 11:52 IST NSE

Annual General Meeting

Eris Lifesciences Annual General Meeting

Eris Lifesciences Limited conducted its 20th Annual General Meeting on September 25, 2026. Shareholders transacted business including the adoption of audited financial statements and director re-appointments.

Read the filing ↗

2 Sep 2026 18:56 IST BSE

Annual General Meeting

Eris Lifesciences Annual General Meeting

Eris Lifesciences will hold its Twentieth Annual General Meeting on September 25, 2026, through video conferencing to transact ordinary and special business.

Read the filing ↗